Renaissance Technologies
ELTX icon

Renaissance Technologies’s Elicio Therapeutics ELTX Stock Holding History

Renaissance Technologies’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-121,631
Closed -$1.3M – 3303
2026
Q1 		$1.3M Buy
121,631
+93,520
+333% +$903K ﹤0.01% 2131
2025
Q4 		$224K Sell
28,111
-20,560
-42% -$187K ﹤0.01% 2859
2025
Q3 		$532K Buy
+48,671
New +$493K ﹤0.01% 2762
2024
Q2 		– Sell
-11,761
Closed -$89K – 3601
2024
Q1 		$89K Sell
11,761
-4,705
-29% -$23.6K ﹤0.01% 3394
2023
Q4 		$137K Buy
+16,466
New +$107K ﹤0.01% 3230
2023
Q2 		– Sell
-9,302
Closed -$54K – 4014
2023
Q1 		$54K Sell
9,302
-2,868
-24% -$19.1K ﹤0.01% 3643
2022
Q4 		$99K Sell
12,170
-8,728
-42% -$79.3K ﹤0.01% 3619
2022
Q3 		$192K Sell
20,898
-452
-2% -$4.72K ﹤0.01% 3399
2022
Q2 		$243K Sell
21,350
-1,020
-5% -$16.3K ﹤0.01% 3562
2022
Q1 		$474K Buy
22,370
+3,260
+17% +$73.6K ﹤0.01% 3230
2021
Q4 		$554K Buy
+19,110
New +$966K ﹤0.01% 3027

Other funds holding ELTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies's ELTX Position: Q2 2026 in Review

Renaissance Technologies sold out of Elicio Therapeutics (ELTX) in Q2 2026, closing a stake of 121,631 shares — an estimated $1.3M sold.

Renaissance Technologies first reported a position in ELTX in Q4 2021 and held it in 11 quarters. The position peaked at $1.3M in Q1 2026. 46 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Renaissance Technologies reported no remaining Elicio Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 121,631 Elicio Therapeutics shares in Q2 2026, an estimated $1.3M.
  • Renaissance Technologies first reported a position in Elicio Therapeutics in Q4 2021 and held it in 11 quarters.
  • Renaissance Technologies's Elicio Therapeutics position peaked at $1.3M in Q1 2026.
  • 46 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.